Zoekresultaten - S. S. Ereshchenko
- Toon 1 - 9 resultaten van 9
-
1
Laboratory monitoring of postvaccination measles immunity door A. A. Ereshchenko
Gepubliceerd in 2020-05-01Measles vaccination In Russian Federation was introduced in 1967. It was assumed that the twodose vaccination regime would lead to a decrease in the incidence and elimination of measles. A number of studies have shown that up to 10% of individuals who received two doses of measles vaccine do not dev...
Volledige tekst
Artikel -
2
ПРОГНОЗИРОВАНИЕ РИСКА НАЛИЧИЯ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ КИШЕЧНИКА У ПАЦИЕНТОВ БЕЗ ЛАБОРАТОРНЫХ ПРИЗНАКОВ ВОСПАЛЕНИЯ... door Yuliya Abbyasovna Khalitova, Yuliya Valerevna Myakisheva, Artem Viktorovich Lyamin, Alena Anatolevna Ereshchenko, Anna Vitalevna Yanchenko
Gepubliceerd in 2019-08-01AbstractSome patients with inflammatory bowel disease (IBD) may not have traditional criteria of inflammation: elevated CRP, ESR and leukocytosis. The aim of this study was to identify additional immunological and biochemical criteria for the risk of IBG in patients with no non-specific laboratory c...
Volledige tekst
Artikel -
3
Outcome prediction of the measles vaccination in healthcare employees door A. A. Ereshchenko, O. A. Gusyakova, N. B. Migacheva, F. N. Gilmiyarova, A. V. Lyamin
Gepubliceerd in 2023-04-01Vaccination is the only guarantee for elimination of measles infection. Healthcare workers have a 13- to 19-fold higher risk for contracting measles than the general population. The number of individuals in the population who did not respond to vaccination is up to 10%, and their accumulation may le...
Volledige tekst
Artikel -
4
POLYMIXIN IN ONCOLOGY CLINICAL PRACTICE door N. V. Dmitrieva, I. N. Petukhova, Z. V. Grigorievskaya, N. S. Bagirova, I. V. Тereshchenko, E. D. Grigorievsky
Gepubliceerd in 2018-07-01The purpose of the study was to present data on polymixin-based antibiotics with activity against infections caused by multidrug- resistant Gram-negative bacteria, such as Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa.Material and methods. The review includes data from...
Volledige tekst
Artikel -
5
Development and experimental basis of local subretinal technique of xenogenic’s injection stem cells labelled by magnetic perticles door Yu. A. Belyy, A. V. Тereshchenko, S. A. Mirgorodskaya, A. A. Temnov, A. D. Semenov, A. V. Revishchin, G. V. Pavlova, N. N. Kust
Gepubliceerd in 2014-10-01Purpose: is to develop a technique for local subretinal injection of xenogeneic stem cells labeled with magnetic particles and to prove experimentally its effectiveness.Material and methods: We used a line of stem cells HEK-293 GFP,labeled with magnetic particles. The study was made on 84 eyes of 42...
Volledige tekst
Artikel -
6
Proinflammatory status of oral fluid in COVID-19 door I. A. Borodina, O. A. Gusyakova, I. A. Selezneva, F. N. Gilmiyarova, A. A. Ereshchenko, O. A. Baldina, N. A. Kolotyeva, O. V. Borisova
Gepubliceerd in 2021-11-01At present, a search for promising ways to diagnose infection caused by SARS-CoV-2 is quite relevant. Oral fluid is not commonly used for assessment of COVID-19 risk. Its molecular profile reflects both local state of the oral cavity, and individual organs and systems, thus suggesting a reliable dia...
Volledige tekst
Artikel -
7
Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases door G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, E. E. Topuzov, R. M. Paltuev, K. Yu. Zernov, V. S. Apollonova, S. S. Ereshchenko, A. V. Petrova, E. K. Zhil’tsova, O. A. Ivanova
Gepubliceerd in 2016-06-01Brain metastases are detectable in 25–35 % of patients with progressive HER-2-positve breast cancer. Even after spreading metastases into the brain, chemotherapy in combination with anti-HER- 2 therapy improves survival due to better control of the systemic disease. The paper presents the results of...
Volledige tekst
Artikel -
8
Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response door P. V. Krivorotko, V. V. Mortada, R. S. Pesotskiy, A. S. Artemyeva, A. S. Emelyanov, S. S. Ereshchenko, G. A. Dashyan, N. S. Amirov, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, M. M. Mortada, K. Yu. Zernov, E. K. Zhiltsova, V. O. Smirnova, Ya. I. Bondarchuk, D. A. Enaldieva, S. N. Novikov, E. A. Busko, A. V. Chernaya, P. I. Krzhivitskiy, R. M. Paltuev, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev
Gepubliceerd in 2022-12-01Background. Achieving a pathologic complete response (pCR) after neoadjuvant systemic therapy (NST) is a predictive factor for improving disease free and overall survival. In triple negative (TN) and HER2-positive breast cancer (BC), the pCR rate exceeds 60 %. Patients with TN and HER2-positive BC w...
Volledige tekst
Artikel -
9
The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer afte... door D. A. Enaldieva, P. V. Krivorotko, E. N. Imyanitov, E. K. Zhiltsova, R. V. Donskikh, A. P. Sokolenko, L. F. Shaykhelislamova, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, K. Yu. Zernov, S. S. Ereshchenko, R. M. Paltuev, A. A. Bessonov, A. S. Artemyeva, R. S. Pesotskiy, N. S. Amirov, A. S. Emelyanov, V. V. Mortada, Ya. I. Bondarchuk, V. V. Semiglazov, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev
Gepubliceerd in 2023-06-01Background. BRCA-associated triple negative breast cancer (TNBC) is considered one of the most aggressive subtypes of breast cancer with high sensitivity to chemotherapy, which leads to increased interest in finding new treatment options for patients with this subtype of breast cancer. Aim. To det...
Volledige tekst
Artikel